Ascendis Pharma A/S Announces Pricing of Public Offering of ADSs

1 year ago

COPENHAGEN, Denmark, Sept. 20, 2024 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced the pricing of its underwritten…

Metagenomi to Present at Chardan’s 8th Annual Genetic Medicines Conference

1 year ago

EMERYVILLE, Calif., Sept. 19, 2024 (GLOBE NEWSWIRE) -- Metagenomi, Inc. (Nasdaq: MGX), a precision genetic medicines company committed to developing…

Kineta, Inc Transitioning from Nasdaq to OTC Markets

1 year ago

Kineta will be trading under the symbol “KANT” on OTC Pink Kineta will continue to pursue strategic alternatives as previously…

Singular Genomics Receives Non-Binding Acquisition Proposal from Concentra Biosciences and Tang Capital

1 year ago

SAN DIEGO, Sept. 19, 2024 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing…

Supernus Pharmaceuticals to Participate in the TD Cowen 4th Annual Novel Mechanisms in Neuropsychiatry Summit

1 year ago

ROCKVILLE, Md., Sept. 19, 2024 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and…

ADR Ratio Change

1 year ago

September 19, 2024 Biodexa Pharmaceuticals PLC(“Biodexa” or the “Company”) ADR Ratio Change Biodexa Pharmaceuticals PLC (Nasdaq: BDRX), an acquisition-focused clinical…

Zenas BioPharma Announces Closing of Full Exercise of Underwriters’ Option to Purchase Additional Shares in Initial Public Offering

1 year ago

WALTHAM, Mass., Sept. 19, 2024 (GLOBE NEWSWIRE) -- Zenas BioPharma, Inc. (“Zenas”), (Nasdaq: ZBIO) a clinical-stage global biopharmaceutical company committed…

GENFIT Reports First Half-Year 2024 Financial Results and Provides Corporate Update

1 year ago

Cash and cash equivalents totaled €61.6 million as of June 30, 2024, excluding the €48.7 million milestone invoiced in June…

Rezolute Reports Fourth Quarter and Full Year Fiscal 2024 Financial Results and Provides Business Update

1 year ago

FDA lifts partial clinical holds on ersodetug for the treatment of congenital HI; Phase 3 sunRIZE study to proceed in…

HUAWEI Innovative Product Launch Unveils Next-Gen Wearables Experience and Seamless Productivity with Tablets

1 year ago

BARCELONA, Spain, Sept. 20, 2024 /PRNewswire/ -- On September 19, at the HUAWEI Innovative Product Launch event in Barcelona, Spain,…